Optiver Holding
NRIX icon

Optiver Holding’s Nurix Therapeutics NRIX Stock Holding History

Optiver Holding’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.52K Sell
356
-152
-30% -$2.52K ﹤0.01% 1382
2025
Q4 		$9.64K Buy
508
+108
+27% +$1.55K ﹤0.01% 1155
2025
Q3 		$3.7K Buy
+400
New +$4.15K ﹤0.01% 2025

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Optiver Holding's NRIX Position: Q1 2026 in Review

Optiver Holding reduced its Nurix Therapeutics (NRIX) stake by 30% in Q1 2026, selling an estimated $2.52K and leaving 356 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Optiver Holding first reported a position in NRIX in Q3 2025 and has held it in 3 quarters since. The position peaked at $9.64K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Optiver Holding held 356 shares of Nurix Therapeutics worth $5.52K as of Q1 2026.
  • Optiver Holding sold 152 Nurix Therapeutics shares in Q1 2026, an estimated $2.52K.
  • Nurix Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1382 holding.
  • Optiver Holding first reported a position in Nurix Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Nurix Therapeutics position peaked at $9.64K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.